GlassScriptPhysician profile
Terra Karma Miller
NPI 1174914907
$9,710.38
in general payments reported to CMS, 2019-2025
50 companies · $2,063 in 2025
The $2,063 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,387 · 2022: $1,532 · 2023: $2,234 · 2024: $2,494 · 2025: $2,063.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,791.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,791.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,558.71 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,309.44 | 2021-2025 | Breztri, Tezspire, Airsupra |
| Amgen INC. | $928.72 | 2021-2025 | Repatha, Otezla, Repatha |
| Lilly USA, LLC | $623.75 | 2021-2025 | Kisunla, Mounjaro, Emgality |
| Boehringer Ingelheim Pharmaceuticals, INC. | $497.07 | 2021-2025 | Jardiance |
| Glaxosmithkline, LLC. | $427.86 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Abbott Laboratories | $425.59 | 2022-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Novartis Pharmaceuticals Corporation | $372.49 | 2022-2025 | |
| Otsuka America Pharmaceutical, INC. | $326.77 | 2024-2025 | Rexulti |
| Aimmune Therapeutics, INC. | $267.46 | 2024 | |
| Idorsia Pharmaceuticals US INC | $228.26 | 2022-2024 | Quviviq |
| Viiv Healthcare Company | $217.21 | 2022-2024 | Apretude |
| Sumitomo Pharma America, INC. | $208.95 | 2023-2025 | Gemtesa |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $197.52 | 2021-2025 | Xifaxan, Trulance |
| Novo Nordisk INC | $191.72 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $157.68 | 2024-2025 | Auvelity, Sunosi |
| Merck Sharp & Dohme LLC | $139.40 | 2021-2024 | Dificid, Delstrigo, Pifeltro |
| Biohaven Pharmaceuticals, INC. | $139.33 | 2021 | |
| Baxter Healthcare | $129.18 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $105.40 | 2024-2025 | Caplyta |
| Alexion Pharmaceuticals, INC. | $94.10 | 2024 | Ultomiris |
| Pfizer INC. | $71.43 | 2021-2023 | |
| Lundbeck LLC | $69.99 | 2025 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $63.88 | 2023 | |
| Collegium Pharmaceutical, INC. | $63.30 | 2023-2025 | Belbuca |
| Kowa Pharmaceuticals America, INC. | $59.90 | 2021-2022 | |
| Corcept Therapeutics | $58.34 | 2024 | Korlym |
| Phathom Pharmaceuticals, INC. | $57.16 | 2025 | Voquezna |
| Csl Behring | $53.46 | 2022-2025 | Haegarda, Andembry |
| Astellas Pharma US INC | $53.18 | 2021-2024 | Veozah |
| Ucb, INC. | $52.65 | 2021 | |
| Sanofi Pasteur INC. | $50.76 | 2022-2023 | |
| Kyowa Kirin, INC. | $46.79 | 2022 | |
| Nestle Healthcare Nutrition INC. | $44.91 | 2021-2023 | |
| Radius Health, INC. | $38.55 | 2021-2024 | Tymlos |
| Medline Industries LP | $37.98 | 2025 | |
| Exact Sciences Corporation | $36.39 | 2023-2025 | Cologuard Collection Kit |
| Mylan Specialty L.P. | $34.86 | 2022 | |
| Esperion Therapeutics, INC. | $34.85 | 2022-2023 | Nexletol |
| Teleflex LLC | $33.72 | 2025 | Urolift |
| Biogen, INC. | $33.34 | 2024 | Spinraza |
| Advanced Respiratory, INC | $29.67 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $25.17 | 2025 | Dupixent |
| Gilead Sciences, INC. | $24.65 | 2025 | Yeztugo |
| Biohaven Pharmaceutical Holding Company LTD. | $17.00 | 2022 | |
| Sanofi-Aventis U.S. LLC | $16.51 | 2021 | |
| Ibsa Pharma INC. | $16.06 | 2022 | |
| Arbor Pharmaceuticals, INC. | $15.14 | 2021 | |
| Dexcom, INC. | $12.28 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $11.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terra Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.